Vbi Vaccines Inc Revenue per Employee (VBIV), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Vbi Vaccines Inc  (NASDAQ: VBIV)
 

Vbi Vaccines Inc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 150.31% in the first quarter 2024, year on year to cumulative value of $9 million, Vbi Vaccines Inc's revenue per employee grew on a trailing twelve months basis to $ 303,581. The productivity of Vbi Vaccines Inc's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 319 other companies have achieved higher revenue per employee. While Vbi Vaccines Inc's total ranking has deteriorated compared to the previous quarter from 0 to 2386. Vbi Vaccines Inc has 31 employees.


What is Sales per Employee Ratio?







VBIV Revenue per Employee (Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Y / Y Revenue Change 150.31 % 191.13 % 1989.59 % 108.09 % 284.92 %
Sales per Employee (TTM) $ 303,581 280,065 262,000 58,548 46,484
VBIV's Total Ranking # 2386 # 0 # 0 # 0 # 0
Seq. Revenue Change 42.32 % -87.12 % 820 % 48.45 % 65.53 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 154
Healthcare Sector # 320
Overall Market # 2386

Revenue per Employee Statistics
High Average Low
$ 481,586 $ 113,323 $ 15,200
(June 30. 2014)   (Mar 31 2022)



Financial Statements
Vbi Vaccines Inc's Revenue MRQ $ 1 Millions Visit VBIV's Income Statement
Vbi Vaccines Inc's Revenues TTM $ 9 Millions Visit VBIV's aggregate revenue growth
What are VBIV's Sales? Visit VBIV's Sales by Segment




Other Ratios
Vbi Vaccines Inc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VBIV's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VBIV's Competitors
Revenue per Employee for VBIV's Suppliers
Revenue per Employee for VBIV's Customers

You may also want to know
VBIV's Sales Growth Rates VBIV's Pe Price to earnings ratio VBIV's Receivables Turnover Ratio VBIV's Stock Quote
VBIV's Net Income Growth Rates VBIV's Ps Price to Sales ratio VBIV's Sales per Employee VBIV's Asset Turnover Ratio
VBIV's Net Margin VBIV's Pb Price to Book ratio VBIV's Financial Strength Ratios VBIV's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:16+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2024Number of Employees Mar 31 2024
Accuray Incorporated  531,224.97 $ 429.761  Million 809 
10x Genomics Inc   530,589.13 $ 625.034  Million 1,178 
Sensus Healthcare Inc   527,566.67 $ 31.654  Million 60 
Vericel Corporation  522,060.30 $ 207.780  Million 398 
Bionexus Gene Lab Corp   514,497.47 $ 9.775  Million 19 
Viatris Inc   512,040.00 $ 15,361.200  Million 30,000 
Organogenesis Holdings Inc   509,922.72 $ 435.474  Million 854 
Angiodynamics Inc   509,900.32 $ 322.257  Million 632 
Avantor Inc   508,644.44 $ 6,866.700  Million 13,500 
Lftd Partners Inc   498,154.18 $ 49.815  Million 100 
Henry Schein Inc   498,040.00 $ 12,451.000  Million 25,000 
Veracyte Inc   497,315.23 $ 375.473  Million 755 
Healthlynked Corp  497,144.30 $ 4.971  Million 10 
Blueprint Medicines Corporation  494,893.47 $ 288.028  Million 582 
Inspire Medical Systems inc   494,807.95 $ 659.579  Million 1,333 
Deciphera Pharmaceuticals Inc   492,704.23 $ 174.910  Million 355 
Bolt Biotherapeutics Inc   492,347.83 $ 11.324  Million 23 
Alpha Pro Tech Ltd   491,430.89 $ 60.446  Million 123 
Maxcyte inc   484,106.59 $ 44.054  Million 91 
Orthofix Medical Inc   473,090.97 $ 759.311  Million 1,605 
Teva Pharmaceutical Industries Limited  471,369.66 $ 16,003.000  Million 33,950 
Teladoc Health Inc   467,732.50 $ 2,619.302  Million 5,600 
Zevra Therapeutics Inc   459,131.15 $ 28.007  Million 61 
Cidara Therapeutics Inc   458,869.57 $ 31.662  Million 69 
Cutera Inc   456,467.44 $ 196.281  Million 430 
Reshape Lifesciences Inc  455,833.33 $ 8.205  Million 18 
Dyadic International Inc   451,074.20 $ 2.255  Million
Thermogenesis Holdings Inc   450,578.95 $ 8.561  Million 19 
Revance Therapeutics Inc   443,155.43 $ 236.645  Million 534 
Bausch Health Companies Inc   441,674.88 $ 8,966.000  Million 20,300 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.